Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01148849
Title Safety Study of MGAH22 in HER2-positive Carcinomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MacroGenics
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
National Cancer Institute Bethesda Maryland 20892 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Seoul National University Hospital Seoul 110-744 Korea, Republic of Details
*Shaded cells indicate that there was no data available from for the field